CN113249444B - DNA probe library for hybridization with FGFR1, 2 or 3 genes and application thereof - Google Patents
DNA probe library for hybridization with FGFR1, 2 or 3 genes and application thereof Download PDFInfo
- Publication number
- CN113249444B CN113249444B CN202110533156.6A CN202110533156A CN113249444B CN 113249444 B CN113249444 B CN 113249444B CN 202110533156 A CN202110533156 A CN 202110533156A CN 113249444 B CN113249444 B CN 113249444B
- Authority
- CN
- China
- Prior art keywords
- artificial sequence
- dna
- fgfr1
- fgfr2
- fgfr3
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The application relates to a DNA probe library for hybridization with fibroblast growth factor receptor (Fibroblast growth factor receptor, FGFR) 1, 2 or 3 genes and application thereof, belonging to the technical field of biological medicine. The application provides a DNA probe library for hybridization with FGFR1, FGFR2 or FGFR3 genes, wherein the DNA probes comprise all probes listed in SEQ ID NO. 1-186. The application provides a method for enriching FGFR1, FGFR2 or FGFR3 gene fragments by utilizing a DNA probe library and detecting related fusion variation by combining with a next generation sequencing technology (NGS). By using the gene enrichment method and the specific DNA probe library obtained by screening, fusion variation in FGFR1, FGFR2 or FGFR3 genes can be accurately obtained by applying the next generation sequencing technology. The method has the advantages of large detection flux, high accuracy, short period and high sensitivity.
Description
Technical Field
The application relates to a DNA probe library for hybridization with fibroblast growth factor receptor (Fibroblast growth factor receptor, FGFR) 1, 2 or 3 genes and application thereof, belonging to the technical field of biological medicine.
Background
The Fibroblast Growth Factor Receptor (FGFR) family mainly includes 4 types of receptors FGFR1, FGFR2, FGFR3 and FGFR4, playing an important role in angiogenesis, vasculogenesis, wound healing and embryonic development. FGFRs are transmembrane proteins, having an extracellular domain, a transmembrane domain and an intracellular tyrosine kinase domain. The signal transduction of the FGF-FGFR pathway is tightly controlled by feedback regulation. Mitogen-activated protein kinase phosphatases and sprutary proteins are upregulated upon FGFR stimulation and antagonize FGF-dependent activation of extracellular signal-regulated kinases. Powerful genetic and functional evidence suggests that FGFR deregulation can lead to the development and progression of cancer. Genetic variation of FGFR1, FGFR2 and FGFR3 has been found and reported in many tumor types (Knight V, cook SJ. De-regulated FGF receptors as therapeutic targets in cancer. Pharmacol Ther 2010;125:105-117;Turner N,Grose R.Fibroblast growth factor signalling:from development to cancer.Nat Rev Cancer 2010; 10:116-129).
Gene fusion belongs to one of genetic variation, and refers to a chimeric gene formed by connecting genes at different positions on two or more chromosomes end to end due to chromosome structural aberration including deletion, repetition, inversion, translocation and the like, and an expression product of the chimeric gene is fusion protein. In gene fusion, all or part of the sequences of two genes are fused to each other to form a new gene. Gene fusion may be the result of chromosomal translocation, intermediate deletion or inversion. Fusion of certain kinases is one of the factors that induces cancer, and inhibitors directed against FGFR fusion have also been documented, including FGFR2 inhibitor Pemazyre (pemigatinib) and irreversible FGFR oral inhibitor futibatinib.
Traditional methods for detecting gene fusion are FISH and IHC, but these methods have low throughput and require separate kit design for individual genes, and fusion partner genes are often difficult to detect and therefore have limitations in clinical practice. The technical field is in need of a sequencing detection scheme with high throughput, high precision and high sensitivity, which can rapidly detect the fusion variation related to the FGFR1, FGFR2 or FGFR3 genes.
Disclosure of Invention
The application aims to solve the technical problem of how to rapidly detect the fusion variation related to the FGFR1, FGFR2 or FGFR3 genes with high flux, high precision and high sensitivity.
In order to solve the above problems, the present application provides a DNA probe library for hybridization with FGFR1, FGFR2 or FGFR3 genes; the DNA probe comprises sequences shown in SEQ ID NO.1 to SEQ ID NO. 186.
The application provides a method for enriching FGFR1, FGFR2 or FGFR3 gene fragments and detecting, which comprises the following steps:
step 1: extracting genomic DNA from human cells, plasma, tissues or FFPE samples, thereby obtaining fragmented double-stranded DNA as a DNA sample library;
step 2: designing a DNA probe hybridized with the FGFR1, FGFR2 or FGFR3 genes as a DNA probe library aiming at the FGFR1, FGFR2 or FGFR3 genes to be enriched; the DNA probe library is the DNA probe library of claim 1;
step 3: hybridizing the DNA sample library with the DNA probe library;
step 4: isolating the hybridization product of step 3, and then releasing the hybridization enriched gene fragment;
step 5: and detecting fusion mutation of the enriched FGFR1, FGFR2 or FGFR3 gene fragments.
Preferably, the DNA sample pool in the above step 1 is composed of double-stranded DNA fragments, and the above step 1 includes extracting whole genomic DNA of a subject and then fragmenting it; wherein the subject is a human and whole genomic DNA is extracted from a cell, plasma, tissue or FFPE sample of the subject.
Preferably, the detection of fusion variation of the enriched FGFR1, FGFR2 or FGFR3 gene fragments in step 5 above employs next generation sequencing techniques. (high throughput sequencing technology is also called next generation sequencing technology; next Generation Sequencing, abbreviated NGS).
The application provides an application of a DNA probe library hybridized with FGFR1, FGFR2 or FGFR3 genes in FGFR1, FGFR2 or FGFR3 gene related fusion variation detection; the application comprises the method.
The application provides a kit for enriching FGFR1, FGFR2 or FGFR3 gene fragments, which comprises the DNA probe library.
The application provides a kit for detecting fusion variation of FGFR1, FGFR2 or FGFR3 gene fragments, which comprises the DNA probe library.
Compared with the prior art, the application has the following beneficial effects:
the application provides a DNA probe library for hybridization with FGFR1, FGFR2 or FGFR3 genes, wherein the DNA probes comprise all probes listed in SEQ ID NO. 1-186. In addition, the application provides a method for enriching FGFR1, FGFR2 or FGFR3 gene fragments by utilizing the DNA probe library and detecting related fusion variation by combining with the next generation sequencing technology (NGS).
The method for enriching the genes and the specific DNA probe library obtained by screening are used for applying the next generation sequencing technology; sequencing the FGFR1, FGFR2 or FGFR3 gene fragments, and further accurately obtaining fusion variation in the FGFR1, FGFR2 or FGFR3 genes. Due to the adoption of the next generation sequencing technology, the detection flux is large, the accuracy is high, the period is short, and the sensitivity is high.
Drawings
FIG. 1 is a flow chart of a method for capturing specific FGFR1, FGFR2 or FGFR3 gene fragments based on hybridization selection.
Detailed Description
In order to make the application more comprehensible, preferred embodiments accompanied with the accompanying drawings are described in detail as follows:
the present application provides a DNA probe pool for hybridization with FGFR1, FGFR2 or FGFR3 genes; the DNA probe comprises sequences shown in SEQ ID NO.1 to SEQ ID NO. 186.
The application provides a method for enriching FGFR1, FGFR2 or FGFR3 gene fragments and detecting, which comprises the following steps:
step 1: extracting genomic DNA from human cells, plasma, tissues or FFPE samples, thereby obtaining fragmented double-stranded DNA as a DNA sample library;
step 2: designing a DNA probe hybridized with the FGFR1, FGFR2 or FGFR3 genes as a DNA probe library aiming at the FGFR1, FGFR2 or FGFR3 genes to be enriched; the DNA probe library is the DNA probe library of claim 1;
step 3: hybridizing the DNA sample library with the DNA probe library;
step 4: isolating the hybridization product of step 3, and then releasing the hybridization enriched gene fragment;
step 5: and detecting fusion mutation of the enriched FGFR1, FGFR2 or FGFR3 gene fragments.
The DNA sample pool in the above step 1 is composed of double-stranded DNA fragments, and the above step 1 includes extracting whole genome DNA of a subject, and then fragmenting it; wherein the subject is a human and whole genomic DNA is extracted from a cell, plasma, tissue or FFPE sample of the subject.
In the step 5, the detection of fusion mutation of the enriched FGFR1, FGFR2 or FGFR3 gene fragments adopts the next generation sequencing technology. (high throughput sequencing technology is also called next generation sequencing technology; next Generation Sequencing, abbreviated NGS).
The application provides an application of a DNA probe library hybridized with FGFR1, FGFR2 or FGFR3 genes in FGFR1, FGFR2 or FGFR3 gene related fusion variation detection; the application comprises the method.
The application provides a kit for enriching FGFR1, FGFR2 or FGFR3 gene fragments, which comprises the DNA probe library.
The application provides a kit for detecting fusion variation of FGFR1, FGFR2 or FGFR3 gene fragments, which comprises the DNA probe library.
The present application provides a method for capturing specific FGFR1, FGFR2 or FGFR3 gene fragments based on hybridization selection. Specifically, the method of the present application comprises: extracting genomic DNA from human cells, plasma, tissues or FFPE samples, thereby obtaining fragmented double-stranded DNA as a DNA sample library; in addition, for FGFR1, FGFR2 or FGFR3 genes to be enriched, designing DNA probes hybridized with the FGFR1, FGFR2 or FGFR3 genes as a DNA probe library; then, hybridizing the DNA sample library with the DNA probe library, so as to enrich FGFR1, FGFR2 or FGFR3 gene fragments from the DNA sample library. After the adaptation treatment, the next generation sequencing technology can be adopted to detect fusion variation of FGFR1, FGFR2 or FGFR3 gene fragments.
The high-throughput sequencing technology is also called next generation sequencing technology (Next Generation Sequencing, abbreviated as NGS), and can sequence hundreds of thousands to tens of millions of molecules in a cell genome at a time, so that the method is widely applied to genome research, is also an important means for detecting genes of tumor patients, can be used for detecting gene mutation of different individuals such as tumor patients, and provides beneficial suggestions and guidance for personalized treatment. NGS is a high throughput, high precision and high sensitivity detection fusion method.
Example 1: FGFR1, FGFR2 or FGFR3 genes of the enriched tissue/FFPE samples and detecting related fusion variants:
in this example, the accuracy of the performance of the present application in FGFR1, FGFR2, or FGFR3 fusion detection is illustrated by detecting 11 FGFR1, FGFR2, or FGFR3 fusion positive samples and 4 FGFR1, FGFR2, or FGFR3 fusion negative samples. The 11 positive samples include 10 positive samples (verified by F1 CDx) provided by Beijing Gin and technology Co., ltd.) and 1 standard purchased from Nanj Corp Bai (Cobioer), and the 3 negative samples include 2 samples (verified by F1 CDx) provided by Beijing Gin and technology Co., ltd.) and 1 standard purchased from Nanj Corp Bai (Cobioer). The initial amount of DNA pool was 100ng. The samples used were tissue and paraffin embedded tissue (FFPE) samples.
1. Preparing a DNA sample library of FFPE samples to be detected:
1. DNA extraction
FFPE samples were subjected to genomic DNA extraction according to QIAamp DNA Mini Kit extraction reagent instructions. Then quantitated using Qubit, tissue/FFPE genomic DNA was required to be greater than 50ng.
2. Library construction
FFPE genomic DNA was broken down to 200-250bp, and then a sample library was constructed according to NEBNExt Ultra II library construction kit. Primers and adaptors were from the biological engineering (Shanghai) Co., ltd.
2.1, terminal repair and addition of "A"
The end repair and addition "a" reactions were configured as follows:
component (A) | Single reaction volume (μL) |
End Prep Reaction Buffer | 7 |
End Prep Enzyme Mix | 3 |
Fragmented DNA | 50μL |
Total volume of | 60μL |
The mixture was thoroughly mixed by shaking and centrifuged, and then incubated on a thermostatic mixer according to the following steps: firstly, incubating for 30min at 20 ℃; then incubated at 65℃for 30min. After incubation, the temperature was reduced to room temperature and centrifuged briefly in a high-speed centrifuge.
2.2 Joint connection
The linker ligation reaction Premix was configured according to the following table:
the amount of linker added varied with the initial amount of DNA, and the correspondence was as follows:
sequentially adding 31 mu L of linker to the reaction tube to connect the reaction Premix and the linker with corresponding volume, and using ddH 2 The volume of O is supplemented to 95 mu L, and the mixture is fully and uniformly mixed by shaking and then centrifuged. Incubation is carried out for 15min at 20 ℃ by a constant temperature mixing instrument. After incubation is completed, the micro high speed centrifuge is briefly centrifuged.
After the ligation reaction was completed, the ligation product was purified using magnetic beads and finally reconstituted into 25. Mu.L TE (pH 8.0).
2.3 Pre-Capture PCR (Non-C-PCR) introduction of index
The reaction components were added to the PCR tubes in the following table order, and negative/positive controls were set up:
component (A) | Single reaction volume (μL) |
index Primer/i7 Primer-P7(10p) | 2.5 |
index Primer/i7 Primer-P5(10p) | 2.5 |
2X KAPA HiFi HotStart Ready Mix | 25 |
Adapter-Ligated library | 20 |
Total volume of | 50 |
Shaking, mixing and centrifuging.
2.3.1, the corresponding relation of the cycle number of the sample of the PCR on-machine is shown in the following table
2.3.2, PCR run-on procedure see Table below
PCR program of Illumina sequencer
PCR program of Gene+Seq2000 sequencer
The Non-C-PCR product was purified and finally dissolved in 31. Mu.L TE (pH 8.0). The purified product was subjected to Qubit-BR quantification and Labchip quality control.
2. Preparing a DNA probe pool for FGFR1, FGFR2, or FGFR3 genes:
DNA probe libraries were prepared for introns 1, 4, 5 and 17 of FGFR1 gene (performance report 1, 4, 17, 1021 detection ranges 1, 5, 17, 1, 4, 5, 17 included in the present specification), introns 1 and 17 of FGFR2 gene, and introns 15 and 17 of FGFR3 gene (performance report 15, 17, 1021 detection range 17, 15, 17 included in the present specification).
In probe design, the probe overlap region, probe length, and GC content are comprehensively considered. The probe overlap region is the number of overlapping bases between each probe. The larger the overlap area, the higher the target area coverage; the smaller the overlap region, even with probe spacing, the lower the sequencing cost. The longer the probe length, the higher the tolerance to Single Nucleotide Polymorphisms (SNPs) upon sequencing.
Finally, the length of the probe is determined to be 120bp, and the GC component is controlled to be between 40% and 60%. After screening, 186 probes meet the standard, and are synthesized by IDT DNA Technologies, and finally a probe library for enriching FGFR1, FGFR2 or FGFR3 gene fragments is formed.
3. Target sequence enrichment and on-press sequencing for FGFR1, FGFR2 or FGFR3 genes:
after the quality control of the amplified library is qualified, the enrichment probe designed by the application is adopted, and hybridization capture is performed by referring to the instruction provided by the chip manufacturer. Finally, eluting back 21 mu L ddH2O band hybridized eluting magnetic beads.
1. Amplification of hybrid Capture products
1.1 removing the magnetic beads of the previous step, purifying the magnetic beads, and finally redissolving 25 mu L ddH 2 O, QC and on-line.
1.2, performing on-machine sequencing by using an Illumina sequencing platform or a Gene+Seq2000 sequencer, and performing on-machine sequencing operation according to an operation instruction provided by a manufacturer. And (3) the data volume requirement of the on-machine: FFPE samples subjected to capture sequencing by using the probe provided by the application can obtain an effective depth of 500X.
4. Information analysis of FGFR1, FGFR2 or FGFR3 gene fusion variants:
the method adopts the low-frequency mutation Enrichment sequencing technology (ER-seq (engineering & Rarallele Sequence) (Chinese patent publication No. CN105063208A, publication date 2015, 11 month and 18 days) which is independently developed by Beijing-g-Ji-Cheng-Co-Ltd, and comprises the following specific steps:
1. based on sequence bases at two ends of an insert as a tag, wherein the insert is a DNA fragment connected with a linker primer in a library, and each fragment forms a pair of paired sequencing sequences through double-end sequencing; taking the first 12bp base of the sequencing sequence 1 of the paired sequencing sequences and the first 12bp base of the sequencing sequence 2 as labels, connecting the smaller labels to form an index of 24bp in the alphabetical sequence, and marking the labels of the sequencing sequence 1 as positive chains in the front by taking the 24bp as the index of the paired sequencing sequences; the tag of sequencing sequence 2 is marked as the inverted strand;
2. externally sequencing the indexes to achieve the aim of gathering all sequencing repeated sequencing sequences of the same DNA template;
3. central clustering is carried out on the clustered sequencing sequences with the same index, each big cluster with the same index is clustered into a plurality of small clusters according to the Hamming distance between the sequences, and the Hamming distance between any two pairs of paired sequencing sequences in each small cluster is not more than 10 so as to achieve the purpose of distinguishing the sequencing sequences with the same index but from different DNA templates;
4. screening the repeated clusters of the same DNA template obtained in the step 3, and if the number of sequencing sequences of the forward strand and the reverse strand reaches more than 2 pairs, carrying out subsequent analysis;
5. the clusters satisfying the condition in 4 are error corrected and a pair of new sequencing sequences without errors are generated. For each sequencing base of the DNA template, if the consistency of a certain base type in the sequencing sequence of the forward strand reaches 80% and the consistency of the base type in the sequencing sequence of the reverse strand also reaches 80%, recording the base of the new sequencing sequence as the base type, otherwise recording as N, and thus obtaining the new sequencing sequence representing the original DNA template sequence;
6. re-aligning the new sequencing sequence to the genome by using BWA-MEM algorithm, and screening out the sequencing sequence with the alignment quality less than 30;
7. counting according to the sequencing sequence obtained in the step 6 to obtain base type distribution of each site in the capture area, and counting the coverage size of the target area, the average sequencing depth, the positive and negative strand interaction rate and the low-frequency mutation rate;
8. SV calling: according to the comparison of the patient sample and the control sample information, SV rolling is carried out; the screening parameters used were: the mutation rate of the control site is less than or equal to 2%, the number of the mutation sequencing sequences after error correction is more than or equal to 2, and the mutation prediction p is less than or equal to 0.05;
9. mutation annotation: annotating the function of the mutation, the number of sequence supports for the mutation, the frequency of the mutation, the amino acid mutation, and the cases of the mutation in the existing mutation database.
5. Detection result
The detection results of 14 fusion negative or positive samples by using the FGFR1, FGFR2 or FGFR3 gene probes disclosed by the application are consistent with the detection results of F1CDx or the reference results of a standard substance, and the detailed detection conditions are shown in the following table, wherein the median fusion mutation frequency is 11.39% (4.07% -75.24%).
A DNA probe pool for hybridization with FGFR1, FGFR2 or FGFR3 genes; the DNA probe comprises sequences shown in SEQ ID NO.1 to SEQ ID NO.186, and the sequences are shown in a sequence table.
While the application has been described with respect to preferred embodiments thereof, it will be understood by those skilled in the art that various changes in form and details may be made therein without departing from the spirit and scope of the application as defined by the appended claims. Equivalent embodiments of the present application will be apparent to those skilled in the art having the benefit of the teachings disclosed herein, when considered in the light of the foregoing disclosure, and without departing from the spirit and scope of the application; meanwhile, any equivalent changes, modifications and evolution of the above embodiments according to the essential technology of the present application still fall within the scope of the technical solution of the present application.
Sequence listing
<120> DNA probe pool for hybridization with FGFR1, 2 or 3 genes and application thereof
<160> 186
<170> SIPOSequenceListing 1.0
<210> 1
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 1
caccgccttc ccacaccctc ccagggccgg ctgcccgtga agtggatggc gcctgaggcc 60
ttgtttgacc gagtctacac tcaccagagt gacgtgtacg tgtcctgcag agctcaggct 120
<210> 2
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 2
ggtgtctgtc ctgggagtct caggacagcc tgacctcacc ttcccctgca gctggtcctt 60
tggggtcctg ctctgggaga tcttcacgct ggggggctcc ccgtaccccg gcatccctgt 120
<210> 3
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 3
tccaccgacg tgagtgctgg ctctggcctg gtgccacccg cctatgcccc tccccctgcc 60
gtccccggcc atcctgcccc ccagagtgct gaggtgtggg gcgggccttc tggggcacag 120
<210> 4
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 4
cctgggcaca gaggtggctg tgcgaagagg ggctcggtgg cacagcgctc accccgcctc 60
ccgccagcag gagtacctgg acctgtcggc gcctttcgag cagtactccc cgggtggcca 120
<210> 5
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 5
agagaagacg gaatcctccc ctgaggagca cgtagagctc cgggtgtcgg gaaagctggg 60
ggagtactgg tccaggggca tggacaggtc caggtactcc tgtgatgggc gagaggaagc 120
<210> 6
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 6
agcgatgggc cgggcccctc ctccctgctc agggaggtgc gtgcacgcag tggggacggc 60
ctgagctctg gctctggcac gggcagcctt acctggttgg aggtcaaggc cacgatgcgg 120
<210> 7
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 7
gctggtatgt gtggttgatg ctgccgtact cattctccac aatgcaggtg tagttgccct 60
tgtcagaggg caccacagag tccattatga tgctccaggt ggcataacgg acctgagggg 120
<210> 8
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 8
aaatgccaaa gggatacatt gagggtccag aggaaaatgc aggccccatg acaatgtcgg 60
caccccgtgg cacctgccct ccatatcaga gcctggtggc acagggcccc aggctgcagg 120
<210> 9
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 9
gttggctagg acaaggcgtg gattgccccc ctaccagccc gttcacactc tgcaagctgg 60
cagatggggt gtaaagactc cagaagtctc cactgtgacg ttcaagatca ttcgtgatcc 120
<210> 10
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 10
ggacagatgt gccttctgca aacactccca aatacaccaa gaatgttccc aactgtgcac 60
ctctcctatt acactaagaa tccagccccc actgtccttg acagctcatt tcaaaaacca 120
<210> 11
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 11
tctcctccag tccagtctct ggtcagaact gtgctcaccc tttcctctct gcctaccaaa 60
gcactgatca cagtctactt tttacggtag ctgctcatgg acatttgcct cctatcagac 120
<210> 12
<211> 119
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 12
tgcaaaattt ttatgggcag gaacgctatc ttgcagcatt taaagcatgg tgtcttgcat 60
gtagtgagtg catggtgaat taatttaaaa tatttctggc tgggtgcggt ggctcaagc 119
<210> 13
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 13
tgcatggtga attaatttaa aatatttctg gctgggtgcg gtggctcaag cctgtaatcc 60
cagctctttg ggaggcccag gcggacagat cacttgaggt catgagttca agaccagcct 120
<210> 14
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 14
ggccaacatg gggaaacccc gtctctacta aaaatacaaa aattagctgg gaatggtggc 60
tgcacatccc aggtactcgg gaggctgagg caggagaatg gcatgaacct gggaggtgga 120
<210> 15
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 15
ctgtcctaag gaagcacgct taaaaaaatg ctgacagaga ttcactgcaa cattatttat 60
tatggtgaaa aaccagaaaa tacctaatat cacaaaatag ttcattaaat tataggactt 120
<210> 16
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 16
tttctgttgt tttttggaga cagagtctca ctctgtcacc caggctagag tgaaatgacg 60
tgatctcagc tcactgcaac ctctgtctcc tgggttcaag caatctcctg cttcagcctc 120
<210> 17
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 17
cccagtagct gggattacag gagcctgcca ccacacatgg ctaatttttt gtatttttag 60
tacagaggag gtttcgccat gttgcccagg ctggtctcga actcctgagc tcaggcaatc 120
<210> 18
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 18
cgcccacctc ggcctcccaa agtgatagga ttttaggcgt gagccaccat gcccagccaa 60
attatgggat tttaaaataa tggaatctta tacagtcatg aaaaattatg tttcaaatat 120
<210> 19
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 19
tcatgcttga aatatatcag gaaaagactc atgttaacaa atgacaaggc aaggaaatta 60
catacatgat gtgatcaact atgtaaaaac catattacag aaagaagact gaagaaatgt 120
<210> 20
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 20
tgtgatcaac tatgtaaaaa ccatattaca gaaagaagac tgaagaaatg tttaaacttt 60
atttgcattt ttttgtattt aaaaatttta atgaataacc tgtataggtg gaaagtatta 120
<210> 21
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 21
cttaaaaaaa tgaaaagcat gtaatcagga cttcctaact cggcctcccc tgttcccatt 60
actctaactt tcgcatgcac acacacgtac cttgtagcct ccaattctgt ggtcaggttt 120
<210> 22
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 22
ggatgtccaa tatggagcta cggctgcccg gggaaagcca agagagacag gcagggtgga 60
gaggagcagc tggtcaggct caggagcagg gcccaggcca ggacctggag gtgtcttgcc 120
<210> 23
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 23
gaaacagtgt ctcacgcata cggtttggtt tggtgttatc tgtttctttc tcctctgaag 60
aggagtcatc atcatcatca tcatcctccg aggaggggag agcatctatg ggaagaagaa 120
<210> 24
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 24
tccatggata ctccacagtg agctcgatcc tccttttcaa actgaccctg aggaaaggaa 60
aaaaacccca aaagttagga gggtctaggt aggggagggg aaaggaaaaa cagaaggtaa 120
<210> 25
<211> 119
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 25
agtatgccat gtggtggctg cttaaagtgt ggacttacta aggcgtccag aagaaaattg 60
tgaagctacc ccaacaatga attagatcat aggtcctggc tgggtgtggt ggtgcaccc 119
<210> 26
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 26
cagcctggcc atggcgaaac cccgtctcta ctaaaaatac aaaaattacc caggcgtggt 60
ggcgcgcacc tgtagtccca gttacttcgg aggctaaggc aagagaatcg cttgaatcca 120
<210> 27
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 27
ggaggcgaag gatgcagtga gctgagattg caccactgca ctccaacctg ggtgacagag 60
cgagattctg tctcaaaaag agaggttata ggtcttaatt ggacagaggg atgctttagt 120
<210> 28
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 28
gattctgtct caaaaagaga ggttataggt cttaattgga cagagggatg ctttagttca 60
attctacagc tatgttttga gtgcagatta cgtgcaagcc tgggaatacc atcatgaggt 120
<210> 29
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 29
caagcctggg aataccatca tgaggttttc caaggtataa acttcaaagt agtatgtgct 60
acaaagtgaa tggtctcatg aaagtcccaa atagttctgc ccttttgtgg gaaacagttt 120
<210> 30
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 30
ttctgccctt ttgtgggaaa cagttttaca aagtgtgcta caattgcagg aggtttgagc 60
atgctgatgg ctccccagca taagacttca ctctgcccag gccaggtgcg gtggctcaca 120
<210> 31
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 31
ctccccagca taagacttca ctctgcccag gccaggtgcg gtggctcaca cctgcaatcc 60
cagcacttcg ggaggctaag gtgggcagat catttgaggt caggagttca agaccaacct 120
<210> 32
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 32
ggccaatatg gtgaaatccc atctctacta aaaatacaaa aattagctgg gcatagtggt 60
acacacctgt aatcccagct actcaggagg ctgagacagg agaattgctt gaactcagga 120
<210> 33
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 33
ggcggaggtt gcagtgagcc gagatcgcag cactgcacta cagcctaggt gacagagtga 60
gactctgtct caaaaaattt aaaaaaaaaa ttttaaaaag accactccat ctagggccaa 120
<210> 34
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 34
caaaaaattt aaaaaaaaaa ttttaaaaag accactccat ctagggccaa ccagtccctc 60
tggtgagaaa taaggggcaa tgaagaatca cggaacaagc taaggaccag taaatggaag 120
<210> 35
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 35
aaatggaagc caggtacaga gataactagt tagtagctgc tggactccat gctcaactcc 60
ccgacctatg caatgaagca gctgaaataa atgacctcct gggtactttc tttttgtctc 120
<210> 36
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 36
ttttgtctct aaaattgtac gaatcacatc catagttcta ccagcctccc ttgcagagag 60
aagaaaaccc tcaccagcta cttacaaaga gcctaagagt gtggagccag gagggatcca 120
<210> 37
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 37
agggatccag ttctccctga tgctggaagg tgacaagtga tgtctgacgg atatgagtcc 60
agaagttgcg gggggcaagg gggcctggga ggtcccactg cagaatcaag gtctattgca 120
<210> 38
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 38
tctattgcaa gcactgagtc aaagatggct cacactggcc ccagttaaaa gaacagaatc 60
tgcagccctt tacccttctc aggtctggtg gggtaaaact taaaactccc cagggtctta 120
<210> 39
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 39
agggtcttaa agaacggatc atagctgtta acatttacca agtgacaaga ctttctgggc 60
actgtcaagg ctacgtgggg gtgaccatct ctattttcca ggtggcttct gtcctaaatg 120
<210> 40
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 40
tcctaaatgc tccagggagc catccaagtt attcagagaa tctacttccc cggaacatgc 60
cctaatgtgg tacttcagcc ctgcctcccc cgagccaggc agggcccctc gcaagtgagt 120
<210> 41
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 41
caagtgagtc agtgctggct ggcagaaaag cccctggatt cttggcttcg ttcacatgtg 60
cttggccagc gggatacaca tgccacacca ctagctccct cccaaggctt actaaaatgt 120
<210> 42
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 42
ctaaaatgtt ttaatgattt caaatcaaaa gagaagtcaa catttctctt tcatttttct 60
acttttacga aaggaatcag aaaagagaaa atgaaatgaa tactgaacac ccactatgta 120
<210> 43
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 43
tcagaaaaga gaaaatgaaa tgaatactga acacccacta tgtaccaagg atgccctaag 60
tagaattaat ttagaactat agtgaggaat taattcattc ctcactataa acttatgggg 120
<210> 44
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 44
gataagtttt attattcctt ttatgcaatg gagaaactga ggctcaaaga ggttaagtac 60
tttactcaag gaaatgtagc tagcatgtaa tagtgcctca aggtttttgg atattagaga 120
<210> 45
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 45
agctagcatg taatagtgcc tcaaggtttt tggatattag agaacagggt gggaggaagt 60
aaataaggga ttgatcaagc ctgactccat ctgatgcaaa ctcaatttat ccaaaccaag 120
<210> 46
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 46
tatccaaacc aagtagataa gggtaaatcc aaggtaactc tggtaacaaa agaggcttga 60
tttgcagttc cattggtcaa agatagaccc ttgtgccagg gcatgttggc tcatacctac 120
<210> 47
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 47
aatcccggga ctttgggagg ctgaggcggg agtatcacct gaggtgggga gttgagacca 60
gactggccaa catggtgaaa ttcctcgtct actaaaaata caaaaattag ctgggtgtgg 120
<210> 48
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 48
tggtgcacgc ctgtaatccc agctactcag gaggctaacg catgagaatt gcttgaattt 60
gggaggtgga ggttgcagtg agccgagatt gcatcactgc actccagcct gggtgacgga 120
<210> 49
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 49
agtgagactc tgtctcaaaa ctaactaact aaaagaaaga cccttggaag cagaccacag 60
atgggccatc taggacactg catggggcac attcccagag ctgggataga agcagtgctt 120
<210> 50
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 50
attcccagag ctgggataga agcagtgctt gccagaggat gcccctaaac ccatattcca 60
caacttacta catcccgaaa atacacctga tgcaggcctg tcacccagaa acgcacacct 120
<210> 51
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 51
tgcaggcctg tcacccagaa acgcacacct gaccaagaaa acccaggtcc cttgctaagt 60
gtcagaatac tgaacaagtt ctcaggttcc aatgggaaag agtggtgtca tgttgagatg 120
<210> 52
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 52
aatgggaaag agtggtgtca tgttgagatg gttaagcttg cttcgacttg gccactctgt 60
ccccagaaaa gcctgccgcc tcctcccagg tgtgggctgg ctgcagaccg ccctctctca 120
<210> 53
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 53
tgtgggctgg ctgcagaccg ccctctctca gctccctggt caatgcactt caaattcatc 60
tgccagcttc cctcttgttc tttcccaaaa aaggtacaaa aagtctcttc ctctcctacc 120
<210> 54
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 54
tttcccaaaa aaggtacaaa aagtctcttc ctctcctacc cctctggccc tcaagtttga 60
catctgtaaa acaaggatgt taagaaaacc tggcctcctg gcaccaactc ctggaataag 120
<210> 55
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 55
ttaagaaaac ctggcctcct ggcaccaact cctggaataa gaagtcagca tacaccccat 60
gccacccgcc tgcaaaaaac acagtgacac aggccactag tccaacatgc tgtctgggac 120
<210> 56
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 56
gtctgggacc ctgccacctc ctgcttcacc tcagtttctc attctactaa ttaatgaatt 60
tttccaatcc cttagaaaca acttccttcc ttcactgctt gacagataga tgtaacctgc 120
<210> 57
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 57
gtaacctgca gccttgcagg tgtacacagc agcttcctcc aagaccctgc agctggttcc 60
ccccgccccg tctctccaat atcagctagg ctcctgggat tcatgcctgc atgcagaggt 120
<210> 58
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 58
tgcagaggtc ctcggtgggg agcagagagg gggcacatct cagtttccca ctcatcagag 60
ggggctgaaa tacttgcctt gcctccatca caggtggtta tgaagactga atgggctgca 120
<210> 59
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 59
tgggctgcat gggtgaaagt gcctgctgtc ttctcactgg agtactgatc caacatacag 60
ggtggacagt gtctggtgag atagcagggg ctggacggac cacgtgacct tgaagctctc 120
<210> 60
<211> 118
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 60
gaagctctcc cacttctaag agaaaaacct atgaatgtca gatctccttg tccaaaaatt 60
atgtaaggaa aactagctga cgaattcatg gccaaatctt tttattcttt ctgagaca 118
<210> 61
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 61
tttattcttt ctgagacaga gtgttgctct gtcacccaag ctagagtgca gtggcacgat 60
ctcaactcac tacaacctcc atcccccaga ctcaagtgat cctcccacct cagcctcccg 120
<210> 62
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 62
agaagctggg ctaattttct gtatatttaa taaaaatggg gtctcaccat gttgcccatg 60
ctggtaatga actcctgggc tcaggagatc cacctacagt ggcctcccaa agtgctggga 120
<210> 63
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 63
ttacaggcat gagccaccac acccagcctg ggtcttttta ttcttgtccg ctggagacag 60
tatgaattca cacccttcca cttatgatct tgccaccctg ggatagtcac ttaaccgttc 120
<210> 64
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 64
taagcctcgg tttcccacct agaggaagcc acatcacagg tgattatgag gctcaaatgg 60
gtggtgtggg tgactgtgcc cattctctcc tctctaaagt accaaccaaa tgtaaagaat 120
<210> 65
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 65
aaccaaatgt aaagaattat gcatttggat ttcagatata atattaagat atttataatt 60
ctctttgtgt agtgctttga gtcactcctt aatagcactc tcaggagatt tggtaattgg 120
<210> 66
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 66
gagatttggt aattggcagc agaaggacag gaacttccaa cctttccaaa ggcatttctc 60
actctccatc ttcatgtctt atattctaga cctgtggccc acacagtggc cactgcacac 120
<210> 67
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 67
acacttgaaa tgtggctggt gctaacggat atgctataag taaaaagtat acaccgcatc 60
ttaaaaactt gttatgaaaa aaatgtaaag tatctcatca ataatttcta tattgattac 120
<210> 68
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 68
atgttcaaat gataatattt tggaaatata gttacattaa ataaaatcta aacaaacaag 60
ttaattaaaa aacaaatatt ggccaggcgc ggtggctcac gcctgtaatc ccagcacttt 120
<210> 69
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 69
gggaggctga ggtgggcaaa tcacgaggtc aagaggtcga caccatcctg gccaacatgg 60
tgaaaccccg tctctactaa aagtacaaaa attagctgcg tgcagtggcg cgcgcctgta 120
<210> 70
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 70
aaaaaaaaaa ttttttttac ctatttcttt cttttaactt aatttccaat gtggcttcta 60
gaaaatctga acatatacat aactcatgtt ataatgttat atttctttct tcctttcttt 120
<210> 71
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 71
ttttctttga gatggagtct tgctctgtca ctcaggctgg agttgcagtg gcgcaatctt 60
ggctcaacca ccgcctcccg ggttcaaacg attctcctgc ctcccaagta gctgggatta 120
<210> 72
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 72
aaagggctgg gattacaggc atgagccact gtgcctggct tttttttttt tttttttttt 60
aaacagggtc ttcctctgtc ccccaggctg gaatgcagtg gtgcaatcac agcttattgc 120
<210> 73
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 73
agcctctgcc tcctaggctc aagtgatcct cccacctcag cctcctgaat agccgggact 60
accagtaagc acgagcatac tcatctaatt tgtgtatttt ttggtagaca cagggtctca 120
<210> 74
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 74
ccatgttgtc caggctcatc tccatctcat gggctcaagc aatccgcctg ccttggcctc 60
ccaaagtgct gggattacag gcatgagcca ctgtgaccag ctgctcatgt tctatttcta 120
<210> 75
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 75
tagggcgcca cagctcgaag caacatccat gcctctgtgc aagactttct tcatgccatt 60
ccttgttctg caacaggcca gcccttccct tttctctgaa ccccacctta agaagctgtt 120
<210> 76
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 76
tcttccataa gactttcttg ggccttctag ctggagaatt tcattcctcc aaatttgcaa 60
accacattac tagcccctct cacatagcac ttaggtcata ttatatgatt gttatttatg 120
<210> 77
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 77
ttcttcattc tcttctctcc ccacgaaact gcaggctcct tcagaacagg gtctgtgcct 60
ccctaacctt tgctaacacc ctcggcacct agcatgtaca caggagatgc caacatgttt 120
<210> 78
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 78
tgtttgttaa ctggatgaat gagtaagtga atgaaggaaa aaaaagggct gatgaaaaga 60
aactgacaga gatactcctc cagaaaaaga ggctgagaat atcagagaaa agcaattagg 120
<210> 79
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 79
gtagtacccc ttgttaacca gccaaactct agtccaaaga accctgagaa aatttctgga 60
caacttggtt cttcagaatt gaggaagtaa caccaaaaca ttaatccctt cagatgagaa 120
<210> 80
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 80
ataagactta tttcttcccc aaagtgacca ttctctactc acatgttgag agggcagggg 60
gcaagtactt aataaacata tggagaaagt tactcagctc agcttgctaa attttagttg 120
<210> 81
<211> 119
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 81
ggtccaatgg aaatgctaat tttttgagtc tctttaaaaa aaaaaagtgt ctaaatgtcc 60
ttggaagtaa gagacatata aaaaattagc aataagtggt caggcacaat ggctcacac 119
<210> 82
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 82
agagacatat aaaaaattag caataagtgg tcaggcacaa tggctcacac ctgtaatccc 60
agcattttgg gaggccgagg ccagcggatt gcttgaggtc aggagttcaa gcccagcctg 120
<210> 83
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 83
gccaacatgg tgaaacacca tctctattaa aaacacaaaa aattagccgg acatggtggc 60
gcatgcttgc aatcccagct actagggagg ctggggcagg agaatcgctt caaccggaag 120
<210> 84
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 84
gcggaggttg cagtgacctg agatagcgcc acagcactcc agcctgggcg acagagcgag 60
actatctcaa aaaaaaaaaa aaaaaaaaaa agcaacaagt gaaacacgaa ctgctgcaca 120
<210> 85
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 85
aaaaaaaaaa aaaaaaaaaa gcaacaagtg aaacacgaac tgctgcacat aatctagaaa 60
accttgctct tgaagacagg atgtactatg agtggaaccc caccaaattc ttgggatagt 120
<210> 86
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 86
tcatccatgt gagggctatt aaatggggga gagggcccta aacatggttt ctttcattgc 60
aggggagaga taaatggtgg cgaggagaga atttctgttt aaagtagatg caaccttagg 120
<210> 87
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 87
aggaaaaaca aatatcctag cccaagtctg acatttcatc ctctctggaa acaccagaat 60
cttctctaaa gctctgcatc tgggctccca ctagtccctg gtgcgttcag gccttttaca 120
<210> 88
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 88
aagctctggg gaagacaaat gtaagacaca aatttcccag gaggaaatta aactatcaag 60
tgatgtgagg ccctttcaga ataagacatt tgaatcaatt ctaactcctt ttcctccagc 120
<210> 89
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 89
agcaacaggc tcaaactttg ctaggatgtt ctataactaa cagccatttt gacgaaagac 60
actttagaaa cgaaggcaag aaaaaagcct ttgtagaagc cggctgctaa acccccaagt 120
<210> 90
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 90
tcataccagc aaatctctca ttttaggagt cttgtttcag gtcaatactg aaaacaaaga 60
gcacaccact aaaagcaaaa cccatggatt ttccttggtc tctaaggctt gaatctgcct 120
<210> 91
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 91
acccagtgtt caattcaatt ttcttgccct ctggagtcca ccaggaataa agctagccca 60
gcctgaggga tgcaccgatg tatctaatcc tctgccccta gggagtgggg gacgcttctc 120
<210> 92
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 92
catttcttcc tgagcctttg cttcccttgc tatcaaaggg ccacctaatg gaactgtcta 60
acaccctcca tggccagagg ccaaggaaaa gaagcaccct aagattgttc aagtggtgcc 120
<210> 93
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 93
cactctggcc tgaattccca ttgggaaaaa tacctcgaaa atgagcattt ctgcaggcat 60
gtttggaaaa gcaggcagtg aagtacgcag tccaagtggc tctcaatctg gatgaacctc 120
<210> 94
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 94
attaaaaagc tgacactcag ctatgactaa gagtaaatgc aacagatatt tcaagcagct 60
cgtcactgat gcagttcata accctcccag ctggagtcag gccccagcag cctcccggtc 120
<210> 95
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 95
cccaaacacc ctgcactcgg agggtcgggg cagccccgga gcttctccta acccactggg 60
ggtaggatat gtaaacaagt cattagggag gcaggccatc ggcaaagacg gccggcaata 120
<210> 96
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 96
gcagaggctg ctgaacctcg gtcaccgaga ggaaggtgga tgacccgggc gtgggggtga 60
ttacccagac caaggcgcgt cccacggggc cctgctactt cgcttttaaa caagcctcag 120
<210> 97
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 97
ggaggaaacc gggagcccgg gccaagggag gaaaatggcc actttctgct aaacagtctc 60
aaggctagat agtattccaa aaaaagcgct ggtccggagg tgcaaagggt agggcacatc 120
<210> 98
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 98
tgcggaggaa acagtcacct taattaccac gtctagagaa agtgcgattt cattacagcc 60
tccaaaacta ccgcccaaag aaggaaacca gagaagtgtt ttcaatttga aagaggctgg 120
<210> 99
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 99
aaagaagcgg gtaagacacc gactctcccc accctcccgg caactttgga ccacaaggcg 60
ctttcctgcc tcaaagacta ttaccaaaca caactcgaaa atccaacccc gctttcaaac 120
<210> 100
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 100
ctgtagccgt tatttaaacg gtaaaacacc ccactttagt ttccggggga tgcggcccaa 60
atcagtcctt aaaaacacac agagagcgcc tctggcagca gccgcccacg cccccggccc 120
<210> 101
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 101
tgcgcaccgg gcttgctccg ggaggggcgc gtgacgccac cgcggggcag ccgagagggg 60
accgcgggct ccgggcaggg caggcgctcc cgcagctcca gctataacac aagggagaga 120
<210> 102
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 102
aagcaacgct ttggttccag aaacttccat cgtcaaggcc agttctggcc agacgcacag 60
ccaaagagcc cccctagtct agcggatgaa ccgttcgcga gtggcacccc ctaaaacctt 120
<210> 103
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 103
ggccccatct cccaagatgc ctctttactg cgcaatccag aaagcacccg gaccgccgcc 60
acccaccagc ggcggcgaat aacttggtga gatcttaaat aactcgggat ccaagggaac 120
<210> 104
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 104
tttcttttct cccccgaatc tcaacgccgc atctccaagt ctccagaaat gttaaggagg 60
gaggtggtca agacaggctg aagaatctga gttttaattt gggggagggg gaggggagga 120
<210> 105
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 105
agagggaagt taataatgcg gctgcggtgt acccgtgtgg ggtgaaacgg aaccagatgc 60
ggctgctaca tctggaaatt gggggtgggg gagtgctggg ggagaaaggc accgtggtaa 120
<210> 106
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 106
tgtttttcaa aagggttgat agcttctggg ctcagaacaa gaaacaggct tcacacccca 60
cccccccccc accaccacca aaaaagtgtc tggctgcctc atagggggtg tgtgttctat 120
<210> 107
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 107
atgaaccccc atctacaagg tccataaaat tcctccgcaa acatgggtcg tagcctcact 60
tttctcccaa ccccaaacat aacggtaggg gaagcgaggt gcagaggggt ctgggccaga 120
<210> 108
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 108
gaagcatacg catcgctgcc gagtgaacca caccggacaa aaaccctcat cccttccccc 60
acctctagga accagattgg gaccgaacgg tccttccgcc cccatcccac acctcggctt 120
<210> 109
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 109
aacgaccgtg ggttgtcctc ccgttcccca aacttccgac cctttcagag accgtccaag 60
tcataagatc accccttctg gaaaggggag tcgtttttcg ctctcagctc aagcagattc 120
<210> 110
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 110
agccatttgg tgacgacacc tccttaaaac ctattccaag agaagctaac ctagccctcc 60
acgtcctccg cagttcatct cccaccccat ccgaccccaa cccgcacccc aggctttccc 120
<210> 111
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 111
gggggtggaa aaggacttag gaatgccccg gatttttagc gttgagccca aagctacctg 60
ctgaattggg ggtgaatccc caaaagggga ccaaaaagac atggagtgga atgcaacaca 120
<210> 112
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 112
cacacataac acacacaacg catcccacct cgccgcccac tcccgccctc ctccccagtc 60
caggaaaccg cgggcctcgc cgccttcgcc ccgggcctgt ccctcccggg actcactgag 120
<210> 113
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 113
gagccgccgc cgcctcgcca gctcccgagc gcgagttgga ggaaaagttg ggcggcggga 60
agagcggcgg gacgagcgca gggagggggc gcaggagacg cggacggagg gaagggaggg 120
<210> 114
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 114
gagacccaag gggcgcggat cgcccgggag ggagccagga ggtgaaaggg gcgggcggcg 60
agcggaggga ggcgccggcc ccggctgggc tgcggcgggc aaagcgcgca gccgggaggc 120
<210> 115
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 115
tccggcgccg ggggccgctc gggacgccaa gcccgcccca gatccggggg cgccgcggct 60
cttacctcgc tcggcgtgga ggttccgcct cgggagagtc cgccgtggct tgtgcgagcg 120
<210> 116
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 116
ggtgaatact gttcgagagg ttggctgagg tccaagtatt cctgaaagaa gggaagagag 60
acgttttatt tcatcttggg tcaggataac aaggtgaata cggttcgaga ggctgactga 120
<210> 117
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 117
ggtccaagta ttcctgaaag aagggaagag aagagtttta tttcaaacac aaactcttga 60
gatgtgggta ttggacgtgg gacaggacag gagaccccta gaaggtgaac agagacccag 120
<210> 118
<211> 119
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 118
cccacctgac ttccacgaag acctccctga gaccacgtct gatgtacccc aggctgtcct 60
tagcttttct cttggaatcc atcataaatc aactattgac aggtagagaa caataaaac 119
<210> 119
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 119
ttggaatcca tcataaatca actattgaca ggtagagaac aataaaacct agttgagcta 60
taggtgctgg gcaggcaact cggcttcaca cggacctaaa taacccgctg agtctacacc 120
<210> 120
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 120
acctcctcac tagagccctt gcttcaaatg cgagccccag caaaatgaaa accggtaaca 60
tgttgtgggt ccccagaccc cctttaagta gttgagacta tgaatattta ttttctgaat 120
<210> 121
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 121
tacattttac tattgtagtt tcggggataa ttgaagggga atacttcttc attcagtggg 60
taatttaaca gatgtaactg attactctca gaagctctcc gagttgaaaa tgtaaacagg 120
<210> 122
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 122
ttcaaaaaag gcttagacat actcatgtat gttaaatcca taatgcactg ttaaaggaaa 60
cttcaggaaa atatcggtta agtttcaaag ttttgaaggt tcgagattca gaaagtgtcc 120
<210> 123
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 123
atcggttaag tttcaaagtt ttgaaggttc gagattcaga aagtgtcctt tgctccccaa 60
ggcatccagt gctggtgctg caaaaagccc tctggatcac cccagggtga cacttcctcc 120
<210> 124
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 124
gtcctttgct ccccaaggca tccagtgctg gtgctgcaaa aagccctctg gatcacccca 60
gggtgacact tcctccgact tgggtgccca cagacgactt tgtatggcct gagggctaaa 120
<210> 125
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 125
ttcctccgac ttgggtgccc acagacgact ttgtatggcc tgagggctaa agatggtctt 60
taacattggt aagcggttga aaaaaaaaat caaaagaaga agaatatctt ataggattaa 120
<210> 126
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 126
aatgaataaa atttatatac aattatataa aattccaatt tcaggatcca taaaatttta 60
ctagaagaca gactagaaca catctattta catattgtct gtggctactt tgaggctaca 120
<210> 127
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 127
gtggcgaagt tgcaacagag accacagggc cggcaaagct gaaaatattt actccctggc 60
cctttacaga aagcagttgc cgacccctgt tctgaagcta tgaaaagctt tctaaattgg 120
<210> 128
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 128
aaagcagttg ccgacccctg ttctgaagct atgaaaagct ttctaaattg ggaacttgtg 60
ggtctctctg cctccactgg gctggcacag tggggcagtt ctgctcacac atccagaagc 120
<210> 129
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 129
aagccaacaa ctattctatg acatgtggtt ttgctgagag ggggcaaaaa gtgcagacca 60
cagcacaaac agcctcagtg ttatcagaaa agagcccatg gaatgttggc aactagacat 120
<210> 130
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 130
acatttttaa agacacacac acacacacac acacacacac acacaaaacc ctctaattca 60
tcaccagggt tggcaagaga aagagtcccc atcccagcat cccagaaggg gaatgtatca 120
<210> 131
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 131
atcagttcca acaacatcag cattaaccac acaactggaa acaaacacgc ccaccacatc 60
aaaagagaac tttttgctta caatgataaa aacgaaattt tgtcctaaat ggaaccgttt 120
<210> 132
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 132
gtttttcttg agcatatggt aatgattttc agaaggaaag aaacttcgat ttttatatcc 60
accagacaat atggcattct gcttttttat tttagggtac tagatacaaa tttcagtatc 120
<210> 133
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 133
tatcaacgga cccactctac atgtaaatat ataaataaat cactttgagc atagacatga 60
gatcattaaa atagaacttt agtgcttttc ccggtttctt tcttttttat ttttattttt 120
<210> 134
<211> 119
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 134
tcaacggacc cactctacat gtaaatatat aaataaatca ctttgagcat agacatgaga 60
tcattaaaat agaactttag tgcttttccc ggtttctttc ttttttattt ttatttttt 119
<210> 135
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 135
ctttagtgct tttcccggtt tctttctttt ttatttttat tttttttttt tttgagacgg 60
agtctcgctc tgtcgccaag gctggaatgc aatggcatga tctcggctca ctgcaacctc 120
<210> 136
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 136
cgcctccccg gttcaagtga ctctcctgcc tcagcctccc ggagtagctg ggattacagg 60
tgcacaccaa cacgcccggc taattttttg tatctttagt agagacaggg tttcaccatg 120
<210> 137
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 137
atgagccact gcgcctgacc aacttttccc agtttctcaa tgaagccata aactttcaga 60
tctgatagga aaaaaacagg gatatcagta gattccaagt ctacagttaa aggaacttat 120
<210> 138
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 138
atactagaaa caacaatttt ggcagaagaa gaaagttggt ttcttccccc ccttgaaccg 60
ttcctttcct ttcaacttct gaaggtcagc tgtattcatt taagtgcaat ctcttccttt 120
<210> 139
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 139
ttatccagca caggccacag tcagacgcat aagataaagc tgctgagcta agacttcata 60
tcactacatt tgattattac tttttaaaaa atcactctaa aactatttcc taaatcagaa 120
<210> 140
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 140
aaattaagtg tattattttc cttctaaaat acttggggga ctttaacttt tttcttgttg 60
agacaattgc atggtttgga gttagtttcc tgtgtaaaag aacactattg tgcatcctca 120
<210> 141
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 141
cattaaatat ctcaaaatac attcattaac aatttctcta tcttaagatt tgactagact 60
tgatgggttt atcatctttc ctgctcagag catatgcttt ccataattat aaaaggcact 120
<210> 142
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 142
atgctttcca taattataaa aggcactcta tctgcatatt gaaggagcca ctgacatggc 60
taaatttgca cagtgagtga cagacgagtg tttattttgt tggcaaggat cataaattat 120
<210> 143
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 143
ctctatctgc atattgaagg agccactgac atggctaaat ttgcacagtg agtgacagac 60
gagtgtttat tttgttggca aggatcataa attattatta ttttcttttt gagatgaagt 120
<210> 144
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 144
gtcttgctct gtctcccaga ctggagtgca gtggcgcaat ctcagtcact gcaaacttca 60
cctcctgggt tcaagcgatt cccctacctc gcctcctaag tagctgggat tacaggcaca 120
<210> 145
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 145
taccaccaca tccaactaat ttttgtattt ttagtagaga cagggtttcg ccatgttggc 60
caggctgctc tcgaactcct ggcctcaggt gatctgccct cctcggcttc ccaaaatgct 120
<210> 146
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 146
ctgggattac aggcgagagc ataaatattt tagggaaaat aaatatttta acaaaaggta 60
catgttttta tgtaaaaatc atgtaagttg ctcattgtag aaaacagtgt atgtttatat 120
<210> 147
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 147
acacctagaa agaggctgca aggcatatag cattaccaac aggatcacat aggatagtac 60
tgtggtaaca gaagctggtg ttagaaaact tcattgtatt ccatcaagca aatgatgacg 120
<210> 148
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 148
aacattatca gtttacccac taatgaccaa agcacagaat caaacttgca caggaatcca 60
agctttttcc catgcacacc aaaatgcaag tgaatactgc ttcccctttc ccactctccc 120
<210> 149
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 149
acataccccg gactgctcca ccagcagcta cactgaaggc agcctcgggg atgtccctct 60
gtctttggtt tcatgagtca gaactcacaa aatgaagttc tgagaaaaat catgatttga 120
<210> 150
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 150
gaggaaccca tagttgaact atctgaccct atggaaaaag aataaacaag accacagact 60
ccaaccaaca gccaacaggg gagtgtgtgt gtaaaacact acgcatgtct cacaagacaa 120
<210> 151
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 151
ccaaggacaa ggggcttcta gaaggaagtt cttacctcat tggttgtgag agtgagaatt 60
cgatccaagt cttctaccaa ctgcttgaac gttggtctct gggagggcac tgcatgccaa 120
<210> 152
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 152
ggtgggctca ggaaccgagg cgctgccgct gctgctgcag tcactaaagg aaagagattg 60
gcgagtcagg gaatcttccc caatgccaaa tcactccagc ccaagtggga taaaaccatt 120
<210> 153
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 153
tttcagcctc tcaaatgtgc gcaaacagag ttctttttca ttatctgcta aatccttcca 60
tcctcacctc agagtcccag gtgataccac cagaccggtc cacagaaatg tgtgaggcta 120
<210> 154
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 154
atctttttaa aagcatactt ttaagaaaca gagataaaac agtagctaca ggactcagat 60
acgtgcagcc acttcagtga ggcaatgtgt gctctcttct actatccact atcgcctcca 120
<210> 155
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 155
ccgccctcaa tgagcagaag caacgtgacc ttagtttcaa gggcaactac aaaagcaagt 60
taaaaatgct cgggttggca taaccaacct cgttcccttc tcttagtcca actgggcttt 120
<210> 156
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 156
agaaagctaa actgttggag gagtctgctc acagctccgt atttctgctg ggctggaggt 60
gagcagtctc ccaccctcac tgtcgctctt gggaagaaag gagaccagca aaatcaaaag 120
<210> 157
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 157
aatcccagga aggctacaga aaattcccac cagtttacac ttgtcaggat tcattttcaa 60
atggagaagt gtctttcagt cttccgccaa gcagccactt acgaagagtg aacacaactg 120
<210> 158
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 158
cagcgcattc aacgcagctg atccaaaaag gacttcgaag cctgaattcc cttcccctgt 60
gactaaatgg cagtccaggg ctgctaaatg tcttcaacct ctgtagaagg gtgaggaaac 120
<210> 159
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 159
tgagcagatg caaattctga tgaataatgc aggaatttat taataatgat gatgtaaatt 60
atgtaaatta tagtcatggt atgtgattgg accaataact ttccatatgc aaacctactg 120
<210> 160
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 160
accaataact ttccatatgc aaacctactg gctaaatttt cagagtataa gttagaagag 60
gacactcaac ttaatattct gttcacccat ttgatccaag ggaaagagaa ttttccaaga 120
<210> 161
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 161
gctaaatttt cagagtataa gttagaagag gacactcaac ttaatattct gttcacccat 60
ttgatccaag ggaaagagaa ttttccaaga aagcttaata tattccaagc aactttaaat 120
<210> 162
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 162
tcactcagta ctctctgtga ctaagggtac agtaaaatgc acaaacttta gagaatgatt 60
aaaacaatca caagaagggg ctcatcaatc tcaggcttca gattctgtga accacaggaa 120
<210> 163
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 163
tgaaccacat tttctaagac tgggggtggc agggaggcct ttaatacaaa aatctctaaa 60
ctctacattt tttatgtacc cactcgatgt ttcaagttat gtcataggat ttcaacactg 120
<210> 164
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 164
ctggagcctc cccaaatctc atcataaaaa ctgctccttt tagctttgac tgaggacaaa 60
aatggaggag ggaaaagaat atgccacatc atttccaaag gaggaataaa gaaaacctct 120
<210> 165
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 165
gcttcaaaga tagcacaggt gaaacggtgt gattcacagc aaaagcaaga aaagtatgtg 60
tgcagtgtgt gtgtgtgtac acggtgtgtg tgcgtgcatg gtgtgtgtgt atgcacggtg 120
<210> 166
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 166
tgtgtgtgta catggtgtgt gcgtgcacgg tgtgtgcatg tgctttcaga tagcttgaaa 60
gatttttcct cttaactttt ctttcctctt agtcaagagc ctcagaagat aatttcggat 120
<210> 167
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 167
ctatttctac atacatgtgg gaggaaagta cacaaacatt ctcattgatt tactaagcat 60
ttgcagaatg caggggaatt ttctacctct aacacgactt caggaacaat cctaagtcct 120
<210> 168
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 168
cgcagaggtt tcaccccagg ctccttcccc ggcctgctcg cccacctgtc cctgcccaga 60
ggagcctcct tggctccagg cagagaaagg tggacagggc gctccgctga atctcaagcc 120
<210> 169
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 169
gttccatcat cccgctagct ggcactagaa atttgcattt cagccatttc caggtccaaa 60
ccccacggca gccccctccc caaaactctg gaaggcggag acctaaggcg acaggtctgc 120
<210> 170
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 170
acagttcctc acaccagtgg acaaaagtat ggtgcgacct cctaggcagg ataattaggt 60
ccccaggctc ggtgttggga atacaggccc agcatgccgc tggcggccac aatcccggct 120
<210> 171
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 171
tcctgccttc aataccataa tccttcctgg agtctgagcc ccagtgaaag ccccagcgtg 60
tttatttttc cccttgaaag ggaactctct tctcagcctg cacgcgggag gagttgtcac 120
<210> 172
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 172
cctccctctg atggatggct cttctcggcc gcccgccccc cggtccattt tcacctcggc 60
acaagcctgc ccccaaagac aggcagagtg acaagcagga agggcttggc tgcggagcgg 120
<210> 173
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 173
tccccatgcc aggcctgtgc tgggctcttc aatttaccat gacattccca aaacccccgc 60
cctccaagaa ggcagaccaa tacagtgccc tccgctttgg gcttccacct aaggggtgat 120
<210> 174
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 174
ctgtccactg ctggctcggc cactgggatc acctggtgtt ttgttcctgg gtagatttca 60
catcaggaaa gtcaacagtg tccggctcct ccaaagtgca gacccatctc ttcgcttaag 120
<210> 175
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 175
gcctccctac ttctccccag cactgagtag gagcgggagc tgtcaagggg tcaaggctag 60
ggggaaattc ctcaacaaat tgaaatctca aaaaacacac actgacccag gaccacaaag 120
<210> 176
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 176
ccctcccggt ttaatgcttg cgtccaatca gaacttgcga gcagcttggg ggtgctcccc 60
accaccaccc cctttcaggg cagcacttct ttcatttgtt tgcctgaaat atcctgtttt 120
<210> 177
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 177
tctccccctt ctcggggcgc taaagagctc agagaaatct gcattttaat tgacattcca 60
gggaaagaga gaggggcgcc tgattgcttt tctattcaaa ctaaacaggc ttttcagatg 120
<210> 178
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 178
aaaatgagtc gagcccggtg gaagatttac agggatttgg gaccagggag acaatggagt 60
tttaaatgtt gatagcgttt cacaccaaac acataatggg tgccctgagt ttgaaagcag 120
<210> 179
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 179
gtttgccttt aagggtaggt tttattgaat tgggagaaag gaaggagggt ctggagaacg 60
gtctgcaagg gagcggggtg cgaggagagc gacggaggct ggtggtcccc gagcgggcct 120
<210> 180
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 180
cctgcgccag gtccgtggtc cgcgagggtc ggagccagcg ccacgcaggg ccctcggctt 60
ttttccccag cgcggccccg tggccgaaaa aaatgagcgc gcaagttaga actcgcctgc 120
<210> 181
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 181
gctttcgaca tctcccagcc gctgcggcag agcaggcagg cgaactagaa aaagtcggtc 60
cagttcgccc cctagcccca ggcgcactgc gctccctcca gcgccgacgg cggctgcggg 120
<210> 182
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 182
cgaggggcgc ccaggcaccg gagccgtcgc ctccccagca gtgccacccc tggccatcgc 60
cacccctacg ggatgtcacc ggccccaccc cagcggcccc ctcccgaaaa aggggtctcc 120
<210> 183
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 183
gcagggcctg gatggtacgg aagttcccag gacacacgga tggggcacct cggagatgac 60
cccgggaacc ggcctgcggg gctgtgccac gggcaggcga accttccgcc cgtctgctct 120
<210> 184
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 184
ggggtcggag aaacgcgccc agtcagcggg aatgcgcccg ccagggtttg acagggaggg 60
gggcgtcaac gccagaagca gatgtcagca tctggatggg ggtagcagag gcagaacttc 120
<210> 185
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 185
cagaacgccg gccgtcagca cgcacccacc tcccccatca cctatgcagc cacagaggga 60
ggacacggag cgtcctccac aatgctagtc cttccgcgcc ccccgcccgg aggacggtgc 120
<210> 186
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 186
acccggcgtc ccgggctccc gtggcgccca cgtccccggc tggcgaagct ccccgaggcg 60
tcttgcgcgg cgattacctt gaatggcaac gctcctccgc gacctgtgtt gtccccgcgc 120
Claims (3)
1. A DNA probe pool for hybridization with FGFR1, FGFR2 or FGFR3 genes; the method is characterized in that: the DNA probe library comprises sequences shown in SEQ ID NO.1 to SEQ ID NO.186, and the detection sites aimed at by the probe library are: introns 1, 4, 5 and 17 of the FGFR1 gene, introns 1 and 17 of the FGFR2 gene, and introns 15 and 17 of the FGFR3 gene.
2. Use of the DNA probe pool of claim 1 in the preparation of a reagent or kit for FGFR1, FGFR2 or FGFR3 gene-related fusion variant detection.
3. A kit for detecting fusion variations of FGFR1, FGFR2 or FGFR3 gene fragments, comprising the DNA probe library of claim 1.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110533156.6A CN113249444B (en) | 2021-05-17 | 2021-05-17 | DNA probe library for hybridization with FGFR1, 2 or 3 genes and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110533156.6A CN113249444B (en) | 2021-05-17 | 2021-05-17 | DNA probe library for hybridization with FGFR1, 2 or 3 genes and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113249444A CN113249444A (en) | 2021-08-13 |
CN113249444B true CN113249444B (en) | 2023-10-13 |
Family
ID=77182099
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110533156.6A Active CN113249444B (en) | 2021-05-17 | 2021-05-17 | DNA probe library for hybridization with FGFR1, 2 or 3 genes and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113249444B (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110218797A (en) * | 2019-07-26 | 2019-09-10 | 上海思路迪医学检验所有限公司 | FGFR Gene Fusion probe, detection method and kit |
CN110241183A (en) * | 2019-06-13 | 2019-09-17 | 南京世和基因生物技术有限公司 | A kind of detection method, kit and the probe library of FGFR fusion |
CN111979307A (en) * | 2020-08-31 | 2020-11-24 | 伯科生物科技有限公司 | Targeted sequencing method for detecting gene fusion |
CN112029865A (en) * | 2020-09-18 | 2020-12-04 | 武汉弘康健基因诊断技术有限公司 | Probe group and gene chip for simultaneously detecting multiple gene mutation types and application thereof |
CN112301115A (en) * | 2020-09-22 | 2021-02-02 | 厦门艾德生物医药科技股份有限公司 | FGFRs gene mutation detection method based on high-throughput sequencing and probe sequence |
-
2021
- 2021-05-17 CN CN202110533156.6A patent/CN113249444B/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110241183A (en) * | 2019-06-13 | 2019-09-17 | 南京世和基因生物技术有限公司 | A kind of detection method, kit and the probe library of FGFR fusion |
CN110218797A (en) * | 2019-07-26 | 2019-09-10 | 上海思路迪医学检验所有限公司 | FGFR Gene Fusion probe, detection method and kit |
CN111979307A (en) * | 2020-08-31 | 2020-11-24 | 伯科生物科技有限公司 | Targeted sequencing method for detecting gene fusion |
CN112029865A (en) * | 2020-09-18 | 2020-12-04 | 武汉弘康健基因诊断技术有限公司 | Probe group and gene chip for simultaneously detecting multiple gene mutation types and application thereof |
CN112301115A (en) * | 2020-09-22 | 2021-02-02 | 厦门艾德生物医药科技股份有限公司 | FGFRs gene mutation detection method based on high-throughput sequencing and probe sequence |
Also Published As
Publication number | Publication date |
---|---|
CN113249444A (en) | 2021-08-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102436654B1 (en) | Humanized non-human animals with restricted immunoglobulin heavy chain loci | |
CN115181778A (en) | Method for selecting therapeutic molecules | |
RU2749715C2 (en) | Rodents characterized by the humanized tmprss gene | |
RU2768285C1 (en) | Oligonucleotides for tau protein expression modulation | |
EP1076700A2 (en) | Human nucleic acid sequences obtained from pancreas tumor tissue | |
KR20120099363A (en) | Generation of induced pluripotent stem cells from cord blood | |
CN109072237A (en) | Reduce the composition and method of TAU expression | |
CN110578002A (en) | Quality control product for detecting circulating tumor DNA mutation and preparation method thereof | |
CN111961713B (en) | Probe composition for screening carrier of pathogenic genes of genetic diseases, kit and preparation method thereof | |
CN111218425A (en) | Humanized transgenic animal | |
CN111032093A (en) | Methods and compositions for controlling myocardial fibrosis and remodeling | |
CN112280868B (en) | Intrahepatic cholangiocellular carcinoma patient prognosis detection biomarker and detection kit | |
CN112270992B (en) | Construction method of intrahepatic cholangiocellular carcinoma patient prognosis evaluation model | |
CN113249444B (en) | DNA probe library for hybridization with FGFR1, 2 or 3 genes and application thereof | |
CN104066839B (en) | The promoter of derived from human gene | |
CN109563516A (en) | GPR156 variant and application thereof | |
CN114220483B (en) | Marker, application, method and device for detecting stability state of microsatellite | |
CN107090027A (en) | Treat the composition and method of neurogenic pain | |
KR102544201B1 (en) | A method for producing genome-edited poultry line having avian influenza virus resistance | |
CN112289450A (en) | Prediction system for prognosis survival period of intrahepatic cholangiocellular carcinoma patient | |
CN111593093B (en) | Method for obtaining substrate sequence efficiently combined in ADAR protein cell, substrate sequence and application | |
CN113473850A (en) | Rodents having genetically modified sodium channels and methods of use thereof | |
RU2812362C2 (en) | Piezotype mechanesentive ion channel component 1 (piezo1) and its use | |
CN116867908A (en) | Physical characterization of telomeres | |
Fong et al. | Experimental and clinical applications of molecular cell biology in nutrition and metabolism |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |